State-owned Hindustan Copper on Tuesday reported 21.44 per cent decline in consolidated net profit at Rs 63 crore for the quarter ended December 31, 2023 due to lower revenue from operations. The company had posted a net profit of Rs 80.20 crore for the year-ago period, Hindustan Copper said in a filing to BSE. Revenue from operations in the quarter dropped to Rs 399.29 crore.

Nifty on Tuesday ended 127 points higher to form a long bull candle with a lower shadow on the daily chart as the index bounced back from near the support at 21,600 level.The short-term trend of Nifty remains choppy with alternative candle formations like bull and bear. A sustainable move above the immediate resistance of 21,800-21,850 levels can open a sharp upside.

Esconet Technologies IPO: The initial public offering of Esconet Technologies is set to open for public subscription on February 16. Esconet Technologies IPO is an SME IPO and a book-built issue of ₹28.22 crore. Esconet Technologies is a provider of high-end supercomputing solutions, and data center facilities that include storage servers, network security, virtualization, and data protection.

Rashi Peripherals, the information and communication technology products distributor, is expected to start its first day of trade with double-digit premium on February 14, backed by the strong IPO subscription numbers and management's positive outlook on earnings. Stable equity market conditions may also support the listing premium. The Rs 600-crore IPO saw 59.71 times subscription.

Kalahridhaan Trendz IPO price band has been set at ₹45 apiece. Kalahridhaan Trendz IPO will open for subscription on Thursday, February 15, and close on Tuesday, February 20. Kalahridhaan Trendz IPO lot size consists of 3,000 shares. Investors can bid for a minimum of 3,000 shares and in multiples thereof. The issue price is 4.5 times of the face value.

Zenith Drugs IPO: The initial public offering (IPO) of small and medium-sized enterprises (SME) Zenith Drugs will be opening for subscription on Monday, February 19, 2024. It comprises a fresh issue with a price band set at ₹75 to ₹79 per share at a face value of ₹10 per share. The SME IPO will close on Thursday, February 22.

In summary, Choice Broking's Sumeet Bagadia has recommended a 'buy' on pharma stock Cipla with a target price of ₹1,600-₹1,660. The stock is currently trading at ₹1,450 and shows signs of an upward movement with support at ₹1,415. Cipla has seen strong performance in the past year and reported a significant increase in net profit for the last quarter.

Indian equities have outperformed major global markets in the past decade and in last one year. Investec brokerage predicts a high probability of a 10% correction in 2024 due to overperformance of large-cap and mid-cap stocks. However, a major crash is unlikely as valuations are not excessive. The brokerage also sees an improving current account and a recovering private investment cycle in India.

Public sector banks continued to post a decent set of numbers in the December quarter on the back of higher interest income, lower credit costs, and improved asset quality. The combined profit of 12 Indian public sector banks (PSBs) in Q3 FY24 jumped 3.84% to ₹30,297 crore as compared to ₹29,175 crore recorded in the same period last year.For the first nine months of the current financial year.

Reviewing the BFSI (banking, financial services and insurance) sector's December quarter (Q3Y24) results so far, brokerage house Anand Rathi noted that the higher cost of fund (CoF) impact seen in banks has not yet hit NBFCs (non-banking financial companies). The incremental CoF, however, is likely higher due to risk weight tweaking by the Reserve Bank of India (RBI), it added.

The Reserve Bank of India (RBI) on February 13 said it will conduct a two-day variable rate repo auction of Rs 25,000 crore on February 14. “On a review of current and evolving liquidity conditions, it has been decided to conduct a Variable Rate Repo (VRR) auction on February 14,” RBI said in a release. The auction will be held between 10:30 AM and 11:00 AM.

The markets have remained volatile in past few sessions. As on one hand the US federal Reserve has not given any indication of an early rate cut against market expectations of a rate cut by March, the various data points also have not been providing any clear road map for the rate cuts. The Sensex and the Nifty that closed with cuts of more than 0.7% on Monday, though rebounded on Tuesday.

Ashish Kacholia portfolio: Fineotex Chemical shares are one of the multibagger stocks that the Indian stock market has produced in the last few years. This Ashish Kacholia-backed chemical stock has risen from around ₹33.75 to ₹400 apiece level on the NSE, delivering over 1,000 percent return to its positional investors in this time.This Ashish Kacholia portfolio stock has been in a bull trend.

On the evening of 29 January, billionaire stock broker Motilal Oswal created a flutter when he declared on microblogging platform X that he would henceforth shun foreign goods in favour of locally produced ones, starting with the purchase of a new Tata Safari, a sport utility vehicle (SUV). Oswal used the hashtag #vocalforlocal, a catchphrase popularized by Prime Minister Narendra Modi.

SoftBank Group Corp.'s stock is surging thanks to the success of Arm Holdings Plc., a chip designer that has almost doubled in value due to its focus on artificial intelligence. SoftBank holds a 90% stake in Arm and their shares rose by 11% on Tuesday. Arm's stock jumped 29% on Monday and it is now valued at $153 billion, surpassing SoftBank's market value of $86 billion.